Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update.
Adult
Aged
Aged, 80 and over
Animals
Antibodies, Bacterial
/ blood
Blood Donors
Borrelia burgdorferi
/ immunology
Female
Humans
Immunoglobulin G
/ blood
Immunoglobulin M
/ blood
Ixodes
/ microbiology
Lyme Disease
/ epidemiology
Male
Middle Aged
Risk Factors
Romania
/ epidemiology
Seroepidemiologic Studies
Tick-Borne Diseases
/ epidemiology
Young Adult
Antibodies
Borrelia burgdorferi
Ixodes ricinus
Lyme disease
Seroprevalence
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
04 Dec 2021
04 Dec 2021
Historique:
received:
28
08
2021
accepted:
16
11
2021
entrez:
5
12
2021
pubmed:
6
12
2021
medline:
18
1
2022
Statut:
epublish
Résumé
The Borrelia burgdorferi sensu lato (s.l.) genogroup is the causative agent responsible for Lyme borreliosis, a common tick-borne infectious disease in some temperate regions of the Northern Hemisphere. In humans, the clinical manifestations of Lyme borreliosis vary from dermatological infection to severe systemic manifestations. In Romania, data on the seroprevalence of Lyme borreliosis and associated risk factors are scarce and outdated, as the only seroprevalence study with a large dataset was published more than 20 years ago. Therefore, the aim of the present study was to evaluate the seroprevalence for Borrelia burgdorferi s.l. in healthy blood donors from six Romanian counties and identify the associated risk factors. The study was conducted among 1200 healthy blood donors aged between 18 and 65 years during November 2019 and September 2020 from six counties in the northwestern and central parts of Romania. A two-tiered testing strategy was applied. Positive and equivocal immunoenzymatic test results for IgG and IgM antibodies were further confirmed by Western blot. Serum samples from 20% of the blood donors had positive or equivocal IgG and IgM ELISA index values. In total, 2.3% of the serum samples for IgG and 1.8% for IgM were positive by Western blot. The seroprevalence for both antibodies varied between 1.5% (Satu-Mare) and 6.5% (Bistrița-Năsăud) in the six counties investigated. The highest seroprevalence was observed in men (4.7%), in blood donors performing their professional activities outdoors (4.2%), and in those aged ≥ 56 years (8%). These findings confirm the presence of specific IgG and IgM antibodies to B. burgdorferi s.l. among healthy blood donors from Romania. Furthermore, potential risk factors, such as gender, age, and behavior, associated with the presence of positive B. burgdorferi s.l. antibodies among healthy blood donors were identified.
Sections du résumé
BACKGROUND
BACKGROUND
The Borrelia burgdorferi sensu lato (s.l.) genogroup is the causative agent responsible for Lyme borreliosis, a common tick-borne infectious disease in some temperate regions of the Northern Hemisphere. In humans, the clinical manifestations of Lyme borreliosis vary from dermatological infection to severe systemic manifestations. In Romania, data on the seroprevalence of Lyme borreliosis and associated risk factors are scarce and outdated, as the only seroprevalence study with a large dataset was published more than 20 years ago. Therefore, the aim of the present study was to evaluate the seroprevalence for Borrelia burgdorferi s.l. in healthy blood donors from six Romanian counties and identify the associated risk factors.
METHODS
METHODS
The study was conducted among 1200 healthy blood donors aged between 18 and 65 years during November 2019 and September 2020 from six counties in the northwestern and central parts of Romania. A two-tiered testing strategy was applied. Positive and equivocal immunoenzymatic test results for IgG and IgM antibodies were further confirmed by Western blot.
RESULTS
RESULTS
Serum samples from 20% of the blood donors had positive or equivocal IgG and IgM ELISA index values. In total, 2.3% of the serum samples for IgG and 1.8% for IgM were positive by Western blot. The seroprevalence for both antibodies varied between 1.5% (Satu-Mare) and 6.5% (Bistrița-Năsăud) in the six counties investigated. The highest seroprevalence was observed in men (4.7%), in blood donors performing their professional activities outdoors (4.2%), and in those aged ≥ 56 years (8%).
CONCLUSIONS
CONCLUSIONS
These findings confirm the presence of specific IgG and IgM antibodies to B. burgdorferi s.l. among healthy blood donors from Romania. Furthermore, potential risk factors, such as gender, age, and behavior, associated with the presence of positive B. burgdorferi s.l. antibodies among healthy blood donors were identified.
Identifiants
pubmed: 34863277
doi: 10.1186/s13071-021-05099-1
pii: 10.1186/s13071-021-05099-1
pmc: PMC8645117
doi:
Substances chimiques
Antibodies, Bacterial
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
596Subventions
Organisme : Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
ID : 57 PCCDI/2018
Informations de copyright
© 2021. The Author(s).
Références
Infect Dis (Lond). 2017 Apr;49(4):277-285
pubmed: 27866446
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1803-8
pubmed: 24838649
Parasit Vectors. 2019 Sep 24;12(1):461
pubmed: 31551069
Exp Appl Acarol. 2010 Oct;52(2):193-7
pubmed: 20232115
Acta Vet Scand. 2020 Aug 3;62(1):42
pubmed: 32746875
J Pediatr. 2016 Jul;174:267-269.e1
pubmed: 27157898
Ticks Tick Borne Dis. 2017 Mar;8(3):375-378
pubmed: 28063832
Ticks Tick Borne Dis. 2015 Apr;6(3):408-13
pubmed: 25838178
Ticks Tick Borne Dis. 2011 Sep;2(3):129-36
pubmed: 21890065
Eur J Epidemiol. 2001;17(9):891-6
pubmed: 12081110
J Med Microbiol. 2005 Apr;54(Pt 4):361-367
pubmed: 15770021
Emerg Infect Dis. 2017 Aug;23(8):1282-1288
pubmed: 28726624
Ticks Tick Borne Dis. 2017 Jan;8(1):1-8
pubmed: 27475874
J Public Health (Oxf). 2017 Mar 1;39(1):74-81
pubmed: 26966194
Transfus Med. 2015 Aug;25(4):284-6
pubmed: 25868417
Front Microbiol. 2021 Mar 09;12:645002
pubmed: 33767683
Parasit Vectors. 2020 Sep 18;13(1):476
pubmed: 32948235
Front Cell Infect Microbiol. 2017 Feb 14;7:36
pubmed: 28261565
Euro Surveill. 2017 Jul 6;22(27):
pubmed: 28703098
Ticks Tick Borne Dis. 2013 Sep;4(5):403-8
pubmed: 23890805
PLoS One. 2012;7(8):e41321
pubmed: 22905101
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2137-2146
pubmed: 28748396
Pathogens. 2020 May 19;9(5):
pubmed: 32438768
Curr Probl Dermatol. 2009;37:178-182
pubmed: 19367102
Clin Infect Dis. 2001 Sep 15;33(6):780-5
pubmed: 11512082
BMC Vet Res. 2012 Aug 18;8:137
pubmed: 22901862
Scand J Infect Dis. 1998;30(5):501-3
pubmed: 10066053
Arch Dermatol. 2006 Jul;142(7):862-8
pubmed: 16847202
Emerg Infect Dis. 2012 Dec;18(12):2089-90
pubmed: 23171510
Clin J Sport Med. 2021 Jul 1;31(4):e200-e206
pubmed: 31241490
Ticks Tick Borne Dis. 2014 Sep;5(5):575-81
pubmed: 24986749
Vector Borne Zoonotic Dis. 2017 Sep;17(9):619-629
pubmed: 28727515
PLoS One. 2015 Feb 19;10(2):e0115520
pubmed: 25695663
Exp Appl Acarol. 2011 Jul;54(3):293-300
pubmed: 21431930
Parasit Vectors. 2012 Dec 28;5:301
pubmed: 23273169
Int J Health Geogr. 2018 Dec 4;17(1):41
pubmed: 30514310
BMC Public Health. 2019 May 17;19(1):597
pubmed: 31101034
Microorganisms. 2021 Feb 12;9(2):
pubmed: 33673353
Emerg Infect Dis. 2015 Jan;21(1):107-10
pubmed: 25531140
Parasitol Res. 2018 May;117(5):1591-1597
pubmed: 29589118
Emerg Infect Dis. 2016 Mar;22(3):550-1
pubmed: 26889789
Vector Borne Zoonotic Dis. 2011 Sep;11(9):1259-62
pubmed: 21612524
Euro Surveill. 2014 Aug 28;19(34):
pubmed: 25188613
Ann Intern Med. 1994 Oct 15;121(8):560-7
pubmed: 8085687
Clin Microbiol Infect. 2019 Oct;25(10):1233-1238
pubmed: 30802651
Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):1027-32
pubmed: 21271270
BMC Infect Dis. 2020 Apr 16;20(1):285
pubmed: 32299372
Ticks Tick Borne Dis. 2013 Apr;4(3):214-7
pubmed: 23339970
Exp Appl Acarol. 2012 Oct;58(2):175-82
pubmed: 22547023
Parasit Vectors. 2015 Oct 08;8:514
pubmed: 26449360
Clin Microbiol Infect. 2020 May;26(5):632-636
pubmed: 31622667
Med Mal Infect. 2019 Mar;49(2):121-132
pubmed: 30528068
Clin Microbiol Infect. 2018 Feb;24(2):118-124
pubmed: 28887186